Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) SHH

Currency In CNY

AD

Valuation

Market Cap41.85B
Enterprise Value47.6B
P/E Ratio12.41
PEG Ratio-1.43
Price/Sales Ratio0.39
Price/Book Ratio0.71
Enterprise/Revenue0.47
Enterprise/EBITDA8.5

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.03
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue77.45B
Revenue/Share54.91
Gross Profit11.76B
EBITDA5.07B
Net Income2.98B
Diluted EPS1.83

Balance Sheet

Total Cash13.29B
Total Cash/Share9.37
Total Debt19.54B
Total Debt/Equity0.5
Current Ratio0.2
Book Value Per Share29.24

Price History

52-Week Change-23.74
52-Week High27.5
52-Week Low19.3
Moving Average 50 Days20.08
Moving Average 200 Days22.32

Statistics

Average Volume8.09M
Shares Outstanding1.56B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.75
Trailing Annual Dividend Yield3.83
Payout Ratio0.83
Last Split FactorN/A
Last Split DateN/A
AD